{"id":"https://openalex.org/W2603796554","doi":null,"title":"Alterations in ETB receptor characteristics during development of hypertension-induced cardiomyocyte hypertrophy are prevented by bosentan","display_name":"Alterations in ETB receptor characteristics during development of hypertension-induced cardiomyocyte hypertrophy are prevented by bosentan","publication_year":2002,"publication_date":"2002-07-01","ids":{"openalex":"https://openalex.org/W2603796554","mag":"2603796554"},"language":"en","primary_location":{"id":"pmh:oai:pure.qub.ac.uk/portal:publications/4e03d7aa-c180-415f-bb2e-50c5a5287216","doi":null,"is_oa":false,"landing_page_url":"https://pure.qub.ac.uk/en/publications/4e03d7aa-c180-415f-bb2e-50c5a5287216","pdf_url":null,"source":{"id":"https://openalex.org/S4306402319","display_name":"Research Portal (Queen's University Belfast)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126231945","host_organization_name":"Queen's University Belfast","host_organization_lineage":["https://openalex.org/I126231945"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Beadnell, G, Kelso, E, Bell, D, Nicholls, P & McDermott, B 2002, 'Alterations in ETB receptor characteristics during development of hypertension-induced cardiomyocyte hypertrophy are prevented by bosentan', European Society of Cardiology Heart Failure Meeting, Strasbourg, France, 02/07/2003 - 05/07/2003 pp. 1.","raw_type":"info:eu-repo/semantics/conferenceObject"},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058144680","display_name":"Gemma Beadnell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gemma Beadnell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108565674","display_name":"Elizabeth J. Kelso","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth J. Kelso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"David Bell","orcid":"https://orcid.org/0000-0002-1107-0157","observed_orcids":["https://orcid.org/0000-0002-1107-0157"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Bell","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1107-0157","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022697388","display_name":"Paul Nicholls","orcid":"https://orcid.org/0000-0001-8669-002X","observed_orcids":["https://orcid.org/0000-0001-8669-002X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Nicholls","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5022597113","display_name":"Barbara J. McDermott","orcid":"https://orcid.org/0000-0002-2710-4833","observed_orcids":["https://orcid.org/0000-0002-2710-4833"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara McDermott","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2710-4833","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.9003999829292297,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.9003999829292297,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.02759999968111515,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.019899999722838402,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endothelin-b-receptor","display_name":"endothelin B receptor","score":0.8019999861717224},{"id":"https://openalex.org/keywords/endothelin-2","display_name":"endothelin-2","score":0.6700000166893005},{"id":"https://openalex.org/keywords/bosentan","display_name":"bosentan","score":0.7760000228881836},{"id":"https://openalex.org/keywords/cardiomyocyte-hypertrophy","display_name":"cardiomyocyte hypertrophy","score":0.8899999856948853},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9039999842643738},{"id":"https://openalex.org/keywords/receptor-desensitization","display_name":"receptor desensitization","score":0.7689999938011169},{"id":"https://openalex.org/keywords/endothelin-receptor-antagonists","display_name":"endothelin receptor antagonists","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C2781109936","wikidata":"https://www.wikidata.org/wiki/Q419769","display_name":"Bosentan","level":4,"score":0.7862949967384338},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.60710209608078},{"id":"https://openalex.org/C167414201","wikidata":"https://www.wikidata.org/wiki/Q1955391","display_name":"Muscle hypertrophy","level":2,"score":0.5907764434814453},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5046123266220093},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4672263562679291},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4484071731567383},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.44419485330581665},{"id":"https://openalex.org/C144980905","wikidata":"https://www.wikidata.org/wiki/Q24721308","display_name":"Endothelin receptor","level":3,"score":0.382843554019928}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:pure.qub.ac.uk/portal:publications/4e03d7aa-c180-415f-bb2e-50c5a5287216","doi":null,"is_oa":false,"landing_page_url":"https://pure.qub.ac.uk/en/publications/4e03d7aa-c180-415f-bb2e-50c5a5287216","pdf_url":null,"source":{"id":"https://openalex.org/S4306402319","display_name":"Research Portal (Queen's University Belfast)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126231945","host_organization_name":"Queen's University Belfast","host_organization_lineage":["https://openalex.org/I126231945"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Beadnell, G, Kelso, E, Bell, D, Nicholls, P & McDermott, B 2002, 'Alterations in ETB receptor characteristics during development of hypertension-induced cardiomyocyte hypertrophy are prevented by bosentan', European Society of Cardiology Heart Failure Meeting, Strasbourg, France, 02/07/2003 - 05/07/2003 pp. 1.","raw_type":"info:eu-repo/semantics/conferenceObject"},{"id":"mag:2603796554","doi":null,"is_oa":false,"landing_page_url":"https://pure.qub.ac.uk/en/publications/alterations-in-etb-receptor-characteristics-during-development-of","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2000200919","https://openalex.org/W2601112411","https://openalex.org/W2597713485","https://openalex.org/W2611044657","https://openalex.org/W7095901963","https://openalex.org/W2602081839","https://openalex.org/W2368336963","https://openalex.org/W2332545497","https://openalex.org/W1968853735","https://openalex.org/W2602628986"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-07T00:00:00"}